Report Detail

Pharma & Healthcare Global Puerarin Injection Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

  • RnM4680301
  • |
  • 26 February, 2026
  • |
  • Global
  • |
  • 102 Pages
  • |
  • GIR
  • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Puerarin Injection market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
This report is a detailed and comprehensive analysis for global Puerarin Injection market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Puerarin Injection market size and forecasts, in consumption value ($ Million), sales quantity (M Units), and average selling prices (US$/Unit), 2021-2032
Global Puerarin Injection market size and forecasts by region and country, in consumption value ($ Million), sales quantity (M Units), and average selling prices (US$/Unit), 2021-2032
Global Puerarin Injection market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (M Units), and average selling prices (US$/Unit), 2021-2032
Global Puerarin Injection market shares of main players, shipments in revenue ($ Million), sales quantity (M Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Puerarin Injection
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Puerarin Injection market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Medisan, Tianjin Tianyao Pharmaceutical, Youcare Pharmaceutical Group, Tiantai Mountain Pharmaceutical, China Res Double-Crane, Actiza Pharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Puerarin Injection market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
50mg/1ml
100mg/2ml
Market segment by Application
Hospital
Clinic
Major players covered
Medisan
Tianjin Tianyao Pharmaceutical
Youcare Pharmaceutical Group
Tiantai Mountain Pharmaceutical
China Res Double-Crane
Actiza Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Puerarin Injection product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Puerarin Injection, with price, sales quantity, revenue, and global market share of Puerarin Injection from 2021 to 2026.
Chapter 3, the Puerarin Injection competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Puerarin Injection breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Puerarin Injection market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Puerarin Injection.
Chapter 14 and 15, to describe Puerarin Injection sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Puerarin Injection Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 50mg/1ml
    • 1.3.3 100mg/2ml
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Puerarin Injection Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Hospital
    • 1.4.3 Clinic
  • 1.5 Global Puerarin Injection Market Size & Forecast
    • 1.5.1 Global Puerarin Injection Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Puerarin Injection Sales Quantity (2021-2032)
    • 1.5.3 Global Puerarin Injection Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Medisan
    • 2.1.1 Medisan Details
    • 2.1.2 Medisan Major Business
    • 2.1.3 Medisan Puerarin Injection Product and Services
    • 2.1.4 Medisan Puerarin Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Medisan Recent Developments/Updates
  • 2.2 Tianjin Tianyao Pharmaceutical
    • 2.2.1 Tianjin Tianyao Pharmaceutical Details
    • 2.2.2 Tianjin Tianyao Pharmaceutical Major Business
    • 2.2.3 Tianjin Tianyao Pharmaceutical Puerarin Injection Product and Services
    • 2.2.4 Tianjin Tianyao Pharmaceutical Puerarin Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Tianjin Tianyao Pharmaceutical Recent Developments/Updates
  • 2.3 Youcare Pharmaceutical Group
    • 2.3.1 Youcare Pharmaceutical Group Details
    • 2.3.2 Youcare Pharmaceutical Group Major Business
    • 2.3.3 Youcare Pharmaceutical Group Puerarin Injection Product and Services
    • 2.3.4 Youcare Pharmaceutical Group Puerarin Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Youcare Pharmaceutical Group Recent Developments/Updates
  • 2.4 Tiantai Mountain Pharmaceutical
    • 2.4.1 Tiantai Mountain Pharmaceutical Details
    • 2.4.2 Tiantai Mountain Pharmaceutical Major Business
    • 2.4.3 Tiantai Mountain Pharmaceutical Puerarin Injection Product and Services
    • 2.4.4 Tiantai Mountain Pharmaceutical Puerarin Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Tiantai Mountain Pharmaceutical Recent Developments/Updates
  • 2.5 China Res Double-Crane
    • 2.5.1 China Res Double-Crane Details
    • 2.5.2 China Res Double-Crane Major Business
    • 2.5.3 China Res Double-Crane Puerarin Injection Product and Services
    • 2.5.4 China Res Double-Crane Puerarin Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 China Res Double-Crane Recent Developments/Updates
  • 2.6 Actiza Pharmaceutical
    • 2.6.1 Actiza Pharmaceutical Details
    • 2.6.2 Actiza Pharmaceutical Major Business
    • 2.6.3 Actiza Pharmaceutical Puerarin Injection Product and Services
    • 2.6.4 Actiza Pharmaceutical Puerarin Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Actiza Pharmaceutical Recent Developments/Updates

3 Competitive Environment: Puerarin Injection by Manufacturer

  • 3.1 Global Puerarin Injection Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Puerarin Injection Revenue by Manufacturer (2021-2026)
  • 3.3 Global Puerarin Injection Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Puerarin Injection by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Puerarin Injection Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Puerarin Injection Manufacturer Market Share in 2025
  • 3.5 Puerarin Injection Market: Overall Company Footprint Analysis
    • 3.5.1 Puerarin Injection Market: Region Footprint
    • 3.5.2 Puerarin Injection Market: Company Product Type Footprint
    • 3.5.3 Puerarin Injection Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Puerarin Injection Market Size by Region
    • 4.1.1 Global Puerarin Injection Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Puerarin Injection Consumption Value by Region (2021-2032)
    • 4.1.3 Global Puerarin Injection Average Price by Region (2021-2032)
  • 4.2 North America Puerarin Injection Consumption Value (2021-2032)
  • 4.3 Europe Puerarin Injection Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Puerarin Injection Consumption Value (2021-2032)
  • 4.5 South America Puerarin Injection Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Puerarin Injection Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Puerarin Injection Sales Quantity by Type (2021-2032)
  • 5.2 Global Puerarin Injection Consumption Value by Type (2021-2032)
  • 5.3 Global Puerarin Injection Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Puerarin Injection Sales Quantity by Application (2021-2032)
  • 6.2 Global Puerarin Injection Consumption Value by Application (2021-2032)
  • 6.3 Global Puerarin Injection Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Puerarin Injection Sales Quantity by Type (2021-2032)
  • 7.2 North America Puerarin Injection Sales Quantity by Application (2021-2032)
  • 7.3 North America Puerarin Injection Market Size by Country
    • 7.3.1 North America Puerarin Injection Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Puerarin Injection Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Puerarin Injection Sales Quantity by Type (2021-2032)
  • 8.2 Europe Puerarin Injection Sales Quantity by Application (2021-2032)
  • 8.3 Europe Puerarin Injection Market Size by Country
    • 8.3.1 Europe Puerarin Injection Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Puerarin Injection Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Puerarin Injection Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Puerarin Injection Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Puerarin Injection Market Size by Region
    • 9.3.1 Asia-Pacific Puerarin Injection Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Puerarin Injection Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Puerarin Injection Sales Quantity by Type (2021-2032)
  • 10.2 South America Puerarin Injection Sales Quantity by Application (2021-2032)
  • 10.3 South America Puerarin Injection Market Size by Country
    • 10.3.1 South America Puerarin Injection Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Puerarin Injection Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Puerarin Injection Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Puerarin Injection Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Puerarin Injection Market Size by Country
    • 11.3.1 Middle East & Africa Puerarin Injection Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Puerarin Injection Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Puerarin Injection Market Drivers
  • 12.2 Puerarin Injection Market Restraints
  • 12.3 Puerarin Injection Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Puerarin Injection and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Puerarin Injection
  • 13.3 Puerarin Injection Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Puerarin Injection Typical Distributors
  • 14.3 Puerarin Injection Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Puerarin Injection. Industry analysis & Market Report on Puerarin Injection is a syndicated market report, published as Global Puerarin Injection Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Puerarin Injection market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,690.04
    4,035.06
    5,380.08
    3,239.88
    4,859.82
    6,479.76
    531,361.20
    797,041.80
    1,062,722.40
    293,712.00
    440,568.00
    587,424.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report